Biosig Technologies, Inc. Announces to Conducts First Patient Cases with Pure EP(Tm) System at Memorial Hospital of South Bend, Indiana
January 12, 2021 at 09:32 am EST
Share
BioSig Technologies, Inc. announced that the Company installed its PURE EP(tm) System and conducted first patient cases at Memorial Hospital of South Bend, part of Beacon Health System, in South Bend, Indiana. PURE EP(tm) System evaluation is being conducted under the leadership of Vinod Chauhan, M.D. and Deepak Gaba, M.D. To date, more than 450 patient cases have been conducted with the PURE EP(tm) System by over 30 physicians across seven clinical sites. BioSig is currently conducting patient cases under the clinical trial titled “Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study)” at Texas Cardiac Arrhythmia Research Foundation (TCARF) in Austin, Texas, Mayo Clinic Florida Campus in Jacksonville, Florida, and Massachusets General Hospital in Boston, MA.
BioSig Technologies, Inc. is a medical technology company focused on deciphering the bodyâs electrical signals, starting with heart rhythms. The Companyâs product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
BIOSIG TECHNOLOGIES, INC. 
